You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism
|
---|---|
Published in |
Molecular Autism, March 2015
|
DOI | 10.1186/s13229-015-0010-7 |
Pubmed ID | |
Authors |
Deepali Mankad, Annie Dupuis, Sharon Smile, Wendy Roberts, Jessica Brian, Toni Lui, Lisa Genore, Dina Zaghloul, Alana Iaboni, Peggy Margaret A Marcon, Evdokia Anagnostou |
Abstract |
Autism spectrum disorder (ASD) is a neurodevelopmental disorder affecting more than 1% of children. It is characterized by social communication deficits and repetitive behaviors/restricted interests. In the absence of any medications known to improve core symptom domains, parents often use complementary alternative treatments, including omega-3 fatty acid supplements. |
X Demographics
The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 6 | 19% |
Saudi Arabia | 3 | 9% |
Netherlands | 2 | 6% |
Norway | 1 | 3% |
Belgium | 1 | 3% |
Ireland | 1 | 3% |
Canada | 1 | 3% |
Turkey | 1 | 3% |
Spain | 1 | 3% |
Other | 1 | 3% |
Unknown | 14 | 44% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 24 | 75% |
Scientists | 4 | 13% |
Practitioners (doctors, other healthcare professionals) | 3 | 9% |
Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 219 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 219 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 47 | 21% |
Student > Master | 32 | 15% |
Student > Ph. D. Student | 22 | 10% |
Researcher | 20 | 9% |
Student > Doctoral Student | 9 | 4% |
Other | 34 | 16% |
Unknown | 55 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 41 | 19% |
Psychology | 31 | 14% |
Nursing and Health Professions | 24 | 11% |
Agricultural and Biological Sciences | 16 | 7% |
Neuroscience | 10 | 5% |
Other | 32 | 15% |
Unknown | 65 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 42. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 June 2022.
All research outputs
#951,245
of 24,920,664 outputs
Outputs from Molecular Autism
#84
of 711 outputs
Outputs of similar age
#12,009
of 268,356 outputs
Outputs of similar age from Molecular Autism
#2
of 11 outputs
Altmetric has tracked 24,920,664 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 711 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.2. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 268,356 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.